Accretive Health (AH) Reports In-Line Q1 EPS; Guides FY12 EPS Below Views

Accretive Health (NYSE: AH) reported Q1 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $253.74 million versus the consensus estimate of $232.88 million.

Accretive Health sees FY2012 EPS of $0.42-$0.50, versus the consensus of $0.54.

For earnings history and earnings-related data on Accretive Health (AH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Group 1 Automotive (GPI) Tops Q1 EPS by 9c
• Enphase Energy tumbles on guidance miss; BMO trims estimates and price target